Funding ExcellencePrescriPtion Progressfor

Prescription for ProgressAs we forge a path for the college over the next five years, we turn to our “Prescription for Progress”

vision statement, which defines our goals:

Prescription: A written direction for the preparation and use of a medicine or remedy.

Progress: A movement toward a goal or to a further or higher stage.

And, that is what is contained in this brochure - The college’s written direction to move toward a higher

stage of education and healthcare. We have even included the dose strength (in dollars) needed to be a

mechanism for change in the profession.

Our mission is to promote the health and welfare of the people of Florida and the nation by preparing

graduates in pharmacy to take independent professional responsibility for the outcome of drug therapy

in patients. We are proud that our graduates have the scientific and cultural background necessary

to assume leadership roles in the profession and community. We now look to increase, not only our

offerings to pharmacists throughout the state and the nation, but to expand the utilization of our

research knowledge by;

• Understanding the body’s mechanisms in specific disease states to design effective drug therapy

(Pharmacodynamics)

• Utilizing genomics for individualized patient treatment (Personalized Medicine)

• Discovering compounds in new areas (Molecular and Chemical Genomic Center)

• Bringing new drugs to the market faster (Pharmacometric and Systems Pharmacology Center)

Our “prescription for progress” won’t come from the state or its ever shrinking dollars. It will be filled

by real people, our alumni and friends, who understand the vital need to support the profession by

supporting its foundation — education and research.

Since its inception in 1923, the University of Florida College of Pharmacy has been a top-tier research

institution and innovator in pharmacy education. Among the first to educate women, the college

also pioneered clinical practice in pharmacy and is a nationally recognized model for distance

education. Today, more than ever, the college is poised to move to the next level of excellence. With

visionary leadership, four established campuses across the state, a renowned faculty, and dedicated

administration, there is only one missing ingredient in the prescription — funding.

In the following pages we have outlined our Prescription for Progress that will allow the college not only

to excel but, most importantly, to become a change maker for the profession and for patient healthcare.

Gratefully,

William H. Riffee Kelly MarkeyDean Senior Director of Development

1

Business & Entrepreneurial Professorship – $4 million

“Creating Health Care Leaders”In the current time of rapid growth and professional change, it is

more important than ever that student pharmacists understand

opportunities and challenges in business and practice management.

Within all sectors of the profession, business acumen is a highly

sought after quality in pharmacist leaders. From the pharmacy

owner to community or hospital pharmacy manager, a shortage of

pharmacists with financial, leadership and management skills exists.

Unfortunately, this is a missing element in our curriculum.

Pharmacy is one of the few professions that require human resource

and business management skills in entry-level positions. A recently

graduated community or hospital pharmacist is often placed in

a position of authority, responsible for coordinating pharmacists,

technicians, pharmacy clerks, and other health care providers.

Knowing how to motivate and effectively manage those around

you while being able to create budgets, project revenue, and

control inventory is extremely valuable in the pharmacy profession.

Unfortunately, students have very little exposure or formal training

in how to optimize all of the resources available to them. Much of

what our students learn will come from on-the-job training.

With independent pharmacy ownership gaining interest with

our students, information on purchasing a pharmacy, qualifying for a loan, funding outlets, specialty

opportunities, and mentoring are urgently needed.

With funds in hand we will be able to wholly support a professor who will teach and mentor students

to be leaders while providing opportunities to acquire knowledge in areas such as accounting, project

management, risk analysis, and ownership.

Our vision is to attract a faculty/practitioner, who can spearhead change and innovation in educating

tomorrow’s pharmacists. A joint appointment in the College of Pharmacy and the Warrington College

of Business also would position this professor to integrate patient care with current business trends.

Pharmacy Tomorrow is a Place… where pharmacy students receive the training and mentoring that empower them to become world-class leaders.

2

Academy for Excellence Endowment – $2 million

“Fueling Innovation and Ensuring Excellence”

Early on, our pharmacy alumni identified a need for non-restrictive funding in the college.

In 1970 the Academy for Excellence was created to “support the college’s leadership with

funding to continue its mission of education, leadership and service.”

Today the Academy for Excellence

provides the resources that

allow the college to initiate new

processes and programs while

strengthening the educational

and outreach efforts. Without the

flexibility of Academy funding,

the ability to grow and expand to

meet the needs of the profession,

the students and the faculty is

severely curtailed. By creating the

“Academy for excellence endowment,” we would establish a stable, dependable income

stream each year to fund initiatives and capture timely opportunities that arise. With an

increase in the college’s flexible funding we will be able to raise the level of excellence across

all departments and continue our tradition of education, leadership and service. Listed below

are projects and programs that would not have happened without Academy funding:

More than 50 UF pharmacy students travelled to Tallahassee to speak to committee

members in support of a House bill that would authorize pharmacists to administer flu

shots. The fund allowed the college to charter a bus for pharmacy students from all four

campuses to advocate for their profession at the state capitol.

UF student pharmacists serve the community by organizing and volunteering

their service for health screening fairs, and prescription drug abuse education in

area high schools.

Ceremonial events that mark the passages of pharmacy school — orientation, white

coat ceremony, parent & family day and graduation.

Faculty and student travel to pharmacy and scientific conferences and competitions to

increase professional and leadership skills.

Pharmacy Museum, which helps preserve the history of pharmacy while educating

future pharmacist about the origins of the profession.

3

Paul Doering Excellence in Teaching Professorship – $2 million

“Teaching the Next Generation”

The faculty is a college’s signature. It is the faculty that

teaches, conducts research and provides the services

that define the college’s reputation and image. Simply

stated, the quality of our college is directly based on

the quality of our faculty. In honor of Paul’s 32 years of

service to the college and his unwavering dedication

to mentoring and educating generations of pharmacy

students, the college has created the “Paul Doering

excellence in teaching Professorship” to recognize a

faculty member whose dedication to student learning

is exemplary.

Once the fund is endowed, it will support the college with permanent resources and encourage other

faculty to not only teach the knowledge, but to also mentor the person. The benefit of an endowment

is it continues to grow in perpetuity since only a portion of the interest is spent each year with the

remainder deposited into the principal, thereby increasing the fund. In essence, endowments ensure

the college will have a dependable stream of revenue regardless of state allocation. The Paul Doering

Excellence in Teaching Professorship will support a faculty member at the college who embodies the

caring and creative qualities that Paul has demonstrated throughout his career.

Pharmacy Tomorrow is a Day… when pharmacy faculty have ample resources to teach and inspire the next generation of pharmacists, educators and researchers.

4

Graduate Student Education & Research Fund – $3 million

“Training Scientists for Tomorrow’s Needs”

All leading academic research programs are driven by the fruitful interactions of graduate

students with their faculty mentors. It is only through recruitment of the most gifted and qualified

candidates that the college can be successful in research and graduate endeavors. In order for us

to achieve this, we must be able to offer competitive packages to attract the best and the brightest

from across the nation. Additionally, a nationally renowned graduate program supports and

retains crucial faculty by providing the necessary resources for faculty to continue their cutting-

edge research and training of future pharmaceutical scientists. In essence, it is the fuel that runs

our research engine and makes new discoveries possible in the treatment and cure of disease to

advance patient care.

Offering a competitive stipend is one part of the package. The college is also responsible for

providing health insurance and fringe benefits as well as tuition costs. The chart below shows the

approximate annual cost for training a graduate student.

There are five graduate programs offered at the University of Florida College of Pharmacy that your gift would support.

Pharmaceutical Outcomes & Policy The program mission is to produce intellectually independent researchers and teachers in

the medication use process. In addition to core requirements, students select an area for

concentration based upon individual interests and future career and research goals. Research in

the department involves health outcomes, which crosses disciplinary boundaries and focuses on

evaluating the efficacy and effectiveness, safety, humanistic and cost outcomes of drug therapy,

medical technologies and pharmacy related health services. Specialty areas in the department

include; Pharmacoeconomics, Patient Safety and Medication use and Pharmacoepidemiology.

Pharmacotherapy and Translational Research (Pharmacogenomics) The program identified a growing need for clinically-trained individuals who have sufficient

research training to facilitate bench-to-bedside, or translational research. One training program

was established to prepare individuals to pursue independent research careers in academia,

industry, or government. Current research focus is on understanding genetic and non-genetic

factors that contribute to variability in drug response. Students conduct hypothesis-driven

clinical research that includes a strong laboratory element. Areas of research include cardiology,

transplant/immunology, asthma/pulmonary, psychiatry, clinical pharmacology/drug metabolism.

Mentoring & Training Annual Cost

Stipend $25,000

Health Insurance & Fringe $4,000

Tuition (computer, equipment, materials, professional travel) $7,500

Department Research Fund $3,500

total Annual graduate student cost $40,000

5

Medicinal Chemistry The program blends physical and biological sciences. The

scope of the field is sufficiently broad to give students with

different science backgrounds a rewarding and challenging

program. Active research include natural products chemistry,

drug delivery systems, organic synthesis of medicinal agents,

metal chalet design, drug metabolism, molecular toxicology,

molecular biology, analytical and forensic chemistry,

molecular modeling and drug discovery. Excellent facilities

for research in the major areas of Medicinal Chemistry and

faculty efforts have been successful in attracting extra mural

research support for the past several years.

Pharmaceutics The program encompasses basic, applied, and clinical investigations in (i) pharmacokinetics/biopharma-

ceutics, (ii) pharmaceutical analysis, (iii) pharmaceutical biotechnology and drug delivery. Faculty members

are involved in collaborative research projects with clinical and other basic scientists within the Health Center

and on campus. Many maintain collaborative ties with scientists in other universities and the pharmaceutical

industry worldwide.

Pharmacodynamics The program develops biomedical scientists with a broad knowledge in the areas of physiology, pharma-

cology, endocrinology and toxicology. Although the research interests of the faculty are broad, there is an

emphasis on the holistic approach to drug actions in living systems. The department has strong programs in

the areas of cardiovascular, reproductive and neuroendocrine physiology and pharmacology, temperature

regulation, neurobiology of aging, autonomic pharmacology, and neuropharmacology.

Graduate Student Education & Research Fund continued

“ As a state university, our resources are limited and we

depend on outside funding. We have developed one of

the best pharmacy and scientific programs in the country.

there is no limit to the imagination of what we can do —

it’s just a matter of matching ideas with resources.”

— Hartmut Derendorf, Ph.D., distinguished professor and chair of pharmaceutics

6

Personalized Medicine – $7 million

“Creating Individualized Patient Care”

The University of Florida College of Pharmacy is on the forefront of Personalized

Medicine, which targets pharmacy medication therapy based on an individual’s genetic

factors thereby ensuring more effective treatment. The last 10 years have seen substantial

advances in defining genetic determinants of disease and drug response, along with

staggering advances in the technologies used to determine genetic information in an

individual. Despite these advances, there has been minimal translation of this information

into clinical practice. The cost for sequencing a personal genome is expected to soon

fall below $1,000. These technological advances, along with discoveries of genetic

determinants of disease risk and drug response, have led to the expectation by many

that eventually an individual’s personal genome will be part of their medical record, from

which information can be pulled to determine disease risk or guide treatment decisions.

To make personalized medicine a reality will require a concerted effort on the part

of health systems, informaticians, laboratory medicine, clinicians, geneticists and

researchers, among others. We are developing a Personalized Medicine Program at the

University of Florida to prepare the UF&Shands health system and the state of Florida to

be leaders in this approach to patient care.

We will initiate the program with a pharmacogenetics example, specifically using the drug

clopidogrel, which recently had a black box warning added to its label to alert clinicians of

the clinical differences in treatment-related outcomes based on genotype. While the initial

focus of this translational project is on a single drug, the larger goal is to build a system

that is ready for wider clinical translation of pharmacogenetics and genetics findings into

clinical practice. In the process of building this clinical translation program, we will also

create a large genetics data repository that will support future research.

In order to build upon our success and maintain excellence in the area of personalized

medicine, funding will be used to create and enhance the following four areas:

Center for Pharmacogenomics

Housed in the college’s Department of Pharmacotherapy and Translational Research,

the center is leading the way for implementation of personalized medicine into

clinical practice. Its mission is to improve patient outcomes by maximizing efficacy

and minimizing toxicity of drug therapy through research, teaching and service

focused on genetically-guided drug therapy decision-making, drug discovery and drug

development.

Targeted diseases are cardiovascular, metabolic, infectious and neuro-psychosocial

disorders.

7

Personalized Medicine continued

Professorship in Personalized Medicine

We must remain competitive to attract and retain top faculty.

A professorship will provide a faculty member with resources to lead

development and implementation of personalized medicine into

clinical practice. Personalized medicine aims to tailor drug treatment

on the basis of molecular and genetic characteristics of an individual

patient and involves application of “omics” technologies such as

pharmacogenomics, proteomics, and metabolomics to patient care.

The professor will advance research in this field and translate that

research into clinical applications.

Graduate Student Education Personalized Medicine Fund

Each graduate student requires a total of $200,000 for four years

of training and mentoring. Our goal is to support the training

of highly qualified individuals and establish a fund to offset

costs associated with training, including stipends, tuition and

research costs associated with their education. The Department

of Pharmacotherapy and Translational Research has established a

Clinical Pharmaceutical Science training program with the goal to

prepare motivated pharmacists to pursue independent research careers in academia, industry, or

government. There is a strong need for clinically-trained individuals who also have rigorous research

training to facilitate bench-to-bedside or translational research. Indeed, the need for clinicians

trained to work in interdisciplinary, team-oriented research environments has been highlighted

by the National Institutes of Health. A current focus of the program is on personalized medicine.

Students in the program conduct cutting-edge research that furthers our understanding of sources

of variability in drug response, accelerating the development of personalized medicine in areas

such as cardiology, diabetes, infectious disease. Excellent research facilities are available for these

graduate students including state-of-the art bioanalytical and pharmacogenomics laboratories, and

an NIH-funded Clinical Translational Science Institute (CTSI) and Clinical Research Center (UF CRC)

for clinical study conduction.

Summer Research Training Program

The Department of Pharmacotherapy and Translational Research offers a summer research

training program in which current UF Doctor of Pharmacy students can participate in translational

research during the summer after their first or second year of pharmacy school. The cost for each

student trained is $6,000. This program has been highly successful with nearly 20 percent of the

participating students (12 of 63) going on to graduate school after obtaining their Pharm.D. degree.

Many of the students are also involved in publications, which makes them more competitive for

pharmacy practice residencies.

8

Center for Molecular Screening and Chemical Genomics – $4 million

“Discovering New Drugs in New Places”

Directed by Hendrik Luesch, Ph.D., an associate professor in the college’s department of

medicinal chemistry, the center is designed to foster early stage drug discovery by providing

the infrastructure, chemical libraries and expertise to screen for disease-relevant targets and

for drug- like disease-modifying molecules that modulate target activity. Screening will focus

on cancer, neurological disorders including Alzheimer’s, inflammatory diseases and infectious

diseases (HCV and malaria).

There is an unmet need for biomedical researchers to move into drug discovery projects, due

to lack of expertise and/or infrastructure. The center provides both drug discovery expertise

and the infrastructure to screen for novel targets and chemical entities that modulate target

activity. Specifically, target discovery and validation requires genomic scale libraries for

gain-of- function and loss-of-function comparison. Natural products and natural product-like

libraries would be a focus for the center.

“ Our Cancer and Alzheimer’s target are close to moving ahead and

with additional funding we could feasibly get into human trial

within two years.” — Hendrik Luesch, center director

9

The center’s scientists and researchers have published two exciting discoveries:

Largazole: A New Discovery A marine compound Dr. Luesch discovered off the coast of Key Largo, inhibits cancer cell growth

in laboratory tests, a finding they hope will fuel the development of new drugs to better battle the

disease. Largazole, is derived from cyanobacteria that grow on coral reefs. Researchers, say it is one

of the most promising they’ve found since the college’s marine natural products laboratory was

established three years ago.

Largazole, discovered and named by Luesch for its Florida location (Key Largo) and its structural

features, seeks out a family of enzymes called histone deacetylase, or HDAC. Overactivity of certain

HDACs has been associated with several cancers such as prostate and colon tumors, and inhibiting

HDACs can activate tumor-suppressor genes that have been silenced in these cancers.

Although scientists have been probing the depths of the ocean for marine products since the

early 1960s, many pharmaceutical companies lost interest before researchers could deliver useful

compounds because natural products were considered too costly and time-consuming to research

and develop.

Many common medications, from pain relievers to cholesterol-reducing statins, stem from natural

products that grow on the earth, but there is literally an ocean of compounds yet to be discovered in

our seas. Only 14 marine natural products developed are in clinical trials today, Luesch said, and one

drug recently approved in Europe is the first-ever marine-derived anticancer agent.

Apratoxin: Discovery to DevelopmentUsing a generally lethal by-product of marine cyanobacteria, known as blue-green algae, Luesch and

his team made it specifically more toxic to cancer cells. The researchers synthesized several apratoxin

compounds that were similar to the original except for slight differences in composition, designing

one that proved to be extremely potent against the cancer cells in cultures and in mice, but without

the overwhelming toxicity. When the scientists gave low doses of the compound to mice with a form

of colon cancer, they found that it inhibited tumor growth without the overall poisonous effect of the

natural product. Even at relatively high doses, the agent was effective and safe.

“This is an extremely interesting discovery that may have the potential to lead to a novel drug, but an

extraordinary amount of additional research is needed before we will know,” said David J. Newman,

D.Phil., chief of the National Cancer Institute’s Natural Products Branch, who was not involved in the

research. “Luesch has found a novel compound and mechanism of action that stops the secretion of

the receptor and the growth factor. If nothing else, he has shown us a new way to kill tumor cells and

has revealed a new chemistry, and those are important steps.”

“ It’s exciting because we’ve found a compound in nature that may one day

surpass a currently marketed drug or could become the structural template

for rationally designed drugs with improved selectivity.”

10

Center for Pharmacometrics and Systems Pharmacology – $4 million

“Advancing Drugs to the Market Faster”

The mission of the center is to foster the availability of safe, efficacious and affordable drugs to

patients. Our vision is to apply the principles of model-based drug development to bridge the

knowledge gap between drug discovery and clinical practice. Our efforts focus on increasing

success from phase I through the beginning of phase III clinical development and enabling

the advancement of individualization drug therapy in order to improve the benefit/risk ratio of

medicines.

Pharmacometrics & System Pharmacology is the combination of two interrelated disciplines

which deal with quantifying disease, drug and clinical trial characteristics in individual and

population levels with the application of systems biology approaches to study drug activities,

targets and effects.

A main objective of the center is to support and advance translational research. By “translating”

scientific discoveries into practical applications, human health will be improved. Scientific

discoveries begin at “the bench” with scientists studying disease and the molecular and cellular

levels and then progress to the clinical level, or the patient’s “bedside.” This “bench-to-bedside”

approach in translational research is a two-way street. Basic scientists provide clinical researchers

with new patient care tools to assess through clinical trials. Then, clinical researchers make

observations about the nature and progression of the disease that stimulates basic scientist’s

investigations. This combined effort makes translational research a true interdisciplinary

approach to improving lives through innovation that leads to discoveries and ultimately cures.

The University of Florida Academic and Research Center at Lake Nona, Fla. is part of Orlando’s newest medical research community.

11

By partnering with other medical organizations in the Lake Nona medical city (Veteran’s Hospital,

Nemours Children Hospital, UCF Medical college, Sanford Burnham/Florida Hospital, MD Anderson

Hospital) our disease and therapeutic areas of research will include:

• Diabetes, obesity, metabolism, cardiovascular diseases and cancer

• General neonatal-to-adolescent pediatrics with special focus on rare diseases/orphan drugs

• Comprehensive disorders of Veterans both war-related and age-related

The establishment of a graduate and post-graduate training program for pharmacometrics, systems

pharmacology and pharmacogenomics will provide a vital pipeline of talent to industry, academia,

and governmental organizations to meet their needs for quantitative skills in predictive modeling and

simulation and design of clinical trials using genetic information. What differentiates our program is the

underlying philosophy of training students to focus more on problem-solving and decision-making and

less on modeling and technical issues – although the latter are obviously important. Students are also

trained to develop their “soft skills” to improve engagement and integration with multidisciplinary teams.

Specifically, funding would support:

• Pharmacometric Education and Research Fund to sustain the infrastructure as well as programs

currently not funded including Speakers Series, and continued growth expenses.

• Professorship in Drug Development and Regulatory Science for a qualified faculty member to

explore innovations related to drug development and regulatory science such as novel clinical study

designs (e.g., enrichment, adaptive), biomarker validation, and specific applications.

• Graduate Student Education Fund to provide support for future scientists in three areas; drug

development, regulatory science and model building and informatics.

Center for Pharmacometrics and Systems Pharmacology continued

Pharmacy Tomorrow is a Belief… that today’s research will lead us to new discoveries, which will improve the quality of life and healthcare for all people from infancy to elder care.

“ With the right resources today, we can expand our impact to

affect more patients in more places, with a greater depth of

drug development solutions, while educating and preparing

quantitative clinical pharmacologists for tomorrow.”

— Lawrence J. Lesko, Ph.D., director of the Center for

Pharmacometrics and Systems Pharmacology

12

Pharmacodynamics Professorship – $2 million

“ Identifying Pathways and Biomarkers for Enhanced Drug Therapy”

The faculty in Pharmacodynamics have research

interests founded in physiology, pharmacology,

endocrinology and neuroscience with emphasis

on understanding the mechanisms behind disease

processes as a basis for drug intervention.

Among the disease processes studied are those

underlying hypertension and cardiac hypertrophy,

metabolic syndrome, anxiety disorders, addiction,

and degenerative neurologic diseases such as

Parkinson’s and age-associated memory loss.

Research in the department includes investigating

the fetal origins of these adult diseases, as well as

effects of environmental exposure, and disease

progression in the aging animal.

The research uses a variety of techniques including in vivo studies in animals, in vitro studies

in tissues, electrophysiologic techniques, and the use of genomic and proteomic methods.

Research efforts investigate pathways and mechanisms involved in disease etiology or

progression, and seek biomarkers for the diseases so effective drug therapies can be identified.

Specifically, our researchers look at the way stress hormones impact the metabolism of food,

the change in food preference (sugar/fat vs. protein) and the cardiovascular response to stress

that often leads to increased calorie intake and thereby and increased risk of diabetes and

obesity. Ongoing research in how these multiple processes integrate together with central

brain mechanisms, suggests new drug targets and new applications of existing drug therapies.

The magnitude and complexity of this research requires a team of investigators and faculty.

Although this team in place, there is a need for a specialist to bring the research out of the lab

and into practice.

In order to reach the next plateau for discovery, we will need to recruit an experienced and

accomplished researcher — whose interests are aligned with the research focus — to build on

existing synergies.

“ In the simplest terms, by understanding this intersection of

neurologic, metabolic and cardiovascular disease our findings will

lead to improved drug therapy and patient care.” — Maureen Keller-Wood, Ph.D., department chair and professor of pharmacodynamics

13

Center for Distance Education – $2 million

“Accessible, Affordable Education”

The UF College of Pharmacy is a natinoally recognized leader in distance education. Beginning

in 1995 with a Pharm.D. program for working professionals, we have subsequently added several

graduate certificates and MS degrees in forensic science, pharmacy regulation, and medication

therapy management. These self-funded programs enable students anywhere in the world to access

quality education from the University of Florida while generating revenue for the college. The

university encourages the development of similar online programs, and other colleges are beginning

to embrace this opportunity. The process, however, is not an easy one; it requires multiple steps,

resources and expertise.

The College of Pharmacy has a well-established infrastructure and proven track record that allows it

to assist other colleges and departments in developing successful and sustainable online programs

while minimizing costs by sharing existing resources. With the creation of the center, the college

would also be able to expand its distance learning offering through the addition of programs in

Quality Assurance, Translational Medicine, Pharmacokinetics and Dietary Supplements.

The Center will utilize and build upon existing

resources in the College of Pharmacy and other

participating Health Science Center colleges

in order to provide 24/7 help desk support,

assistance with online course development,

including instructional and graphic design,

business plan development, registration and

student support, and identify and encourage

collaborative educational efforts. Advice and

assistance with marketing will also be available.

The center will be positioned to facilitate

International outreach through existing and

future partnerships with overseas institutions.

Private funding is required to provide essential

start-up funds and support the hiring of a

center director.

“Teachers affect eternity; no one can tell where their influence stops.” — Henry Brooks Adams

14

William H. Riffee, Ph.D. Dean’s Endowment – $3 million

“Keeping Vision Alive”As senior leadership throughout pharmacy education begins to retire, the college needs

to be in a position to attract an innovative and visionary leader to take the college to

the next level with respect to the training of future practicing health professionals and

leaders in the profession as well as the development of pharmaceutical scientists to

advance discovery and application of new pharmaceuticals to treat human diseases.

When Bill started as Dean in 1996, he saw the need to reduce dependency on state

resources and embarked on a plan to generate entrepreneurial revenue to replace

state dollars. As a result of his vision, today the college has four campuses, seven online

Master’s degrees, a Medication Therapy Management Call Center and is the leader in

Working Professional PharmD (WPPD) programs. In fact, this fiscal year the college was

the only college at the university to have a budget increase due in large part to changes

that were implemented in previous years.

As he began to strategize about the leadership succession plan for the college, he

wanted the next dean to have the necessary resources required to efficiently implement

changes and the flexibility to act on current issues in the profession. The William H. Riffee

Endowment was created in response to this need with a lead commitment from Dan and

Jackie Devine. The Devines wanted their gift to recognize the visionary leadership and

work Dean Riffee initiated and ensure that future leaders had the resources to build on

the foundation established during his tenure and that of previous Deans.

The intent of the fund is to support teaching, research, academic programs and

technology enhancements including support for students and faculty at the Dean’s

discretion. Further funds will enhance the endowment principal thereby increasing the

annual spendable amount to initiate new innovations in education and research while

ensuring the continuation of successful programs.

“ It’s remarkable to see the educational opportunities that

developed in the College of Pharmacy in the time he has been

dean, and I am proud to have been associated with the college

during these extraordinary times.” — Dan Devine

“ We bridge between what is being done now in patient care

and what will happen in the future as educators for the next

generation of practitioners.” — Dean William Riffee, Ph.D.

15

Business & entrepreneurial Professorship – $4 million

“Creating Health Care Leaders”

Academy for excellence endowment – $2 million

“Fueling Innovation and Ensuring Excellence”

Paul Doering excellence in teaching Professorship – $2 million

“Teaching the Next Generation”

Graduate Student Education & Research Fund – $3 million

“Training Scientists for Tomorrow’s Needs”

Personalized Medicine – $7 million

“Creating Individualized Patient Care”

center for Molecular screening and chemical genomics – $4 million

“Discovering New Drugs in New Places”

center for Pharmacometrics and systems Pharmacology – $4 million

“Advancing Drugs to the Market Faster”

Pharmacodynamics Professorship – $2 million

“Identifying Pathways & Biomarkers for Better Drug Therapy”

center for Distance education – $2 million

“Accessible, Affordable Education”

Deanship – $3 million

“Keeping Vision Alive”

TOTAL $33 million

Prescription for Progress

Your Name Here

16

PRESCRIPTION for PROGRESS

Yes, i want to contribute to the path of progress!

I want to ensure progress at the college and commit to a 5-Year PLEDGE for:

$____________ $50,000* $35,000 $20,000 $10,000

First payment, as shown below, is due now, remaining payments will be billed annually.

$50,000 pledge: $10,000/year | $35,000 pledge: $7,000/year | $20,000 pledge: $4,000/year | $10,000 pledge: $2,000/year

(*Pledges may be greater than $50,000, however, minimum pledge is $5,000.)

Enclosed is my first initial pledge payment of $__________________________

I want to give a one-time gift of $ ____________________

Please apply my above Gift or Pledge to the following Established Funds:

Academy for Excellence Paul Doering Excellence in Teaching Professorship Business & Entrepreneurial Professorship

Debbie Klapp Graduate Student and Education Fund William H Riffee Dean’s Endowment

Pharmacometric & Systems Pharmacology Center Other ______________________________

i would like to commit to a lead gift ($75,000+) to initiate progress in the following area(s):

Personalized Medicine Fund Pharmacodynamics Professorship Center for Distance Education

Center for Molecular Screening & Chemical Genomics Other Area______________________________

i want to create my legacy at the college with a Planned gift (bequest, annuity, trust, life insurance or retirement beneficiary, property) and would like someone to contact me.

COnTACT InFORmATIOn

NAME CLASS YEAR

ADDRESS: STREET CITY STATE ZIP

PHONE(S) E-MAIL

SIGNATURE DATE

PAYmEnT InFORmATIOn Check (payable to UF Foundation, Inc.) Credit (Visa, MC, Discover, AmEx) Please call us at 352-273-6605 for credit card payments. I am interested in setting up monthly recurring charges on my credit card

thank you for your commitment to the college of Pharmacy, our students, and faculty!

Please return this form by mail or fax, to:Kelly Markey, Senior Director of Development • College of Pharmacy • PO Box 103570 • Gainesville, FL 32610-3570

Tel: (352) 273-6605 • Fax: (352) 273-6607 • Email: markey@cop.ufl.edu

The University of Florida Foundation, Inc. is a 501(c)(3) corporation (Federal ID number: FE ID 59-0974739) Contributions are tax deductible to the extent

provide by law. All gifts will be sent a receipt and thank you letter acknowledging your contribution.

REM

OV

E TH

IS P

AG

E TO

MA

IL G

IFT

FOR

M

Gift/Pledge Form

PRESCRIPTION for PROGRESS

Lawrence and Linda DuBow | Lawrence DuBow Family graduate student endowment“ Pharmacy had just always been very good to me — and pharmacy in the

state of Florida has been particularly good to me in my work life. So, what

better way to give back than to the University of Florida and its pharmacy

program?” — Laurie DuBow

shawn and Katie Anderson | Vogel Anderson Exceptional Leader Fund“ We both appreciated the help we received while students at the college so

much and wanted to not only pay it forward but to encourage leadership in the

profession.” — Katie Vogel Anderson

David L. Bean | Helen and David Bean Campus of the University of Florida college of Pharmacy, orlando“ My education from the University of Florida gave me a great opportunity to pursue a

business I loved,” There comes a time to give back to the university, which has been so

influential in my life.” — David Bean

Bill Mcclintock | Academy for excellence “ My UF pharmacy professors Oscar Araujo and Gene Gramling influenced me during my

UF years. My time at the UF College of Pharmacy has taught me how to work hard, and

gave me the tools to be successful as a professional. I then used those tools to learn

management and that has helped me immensely over the years.”

— Bill McClintock, MedDispense President and CEO

richard neal | neal Family Scholarship “ I was the only one of the Neal side of the family to go to college. With the push

and the promise made to my grandma before she passed away and the help

of my father paying for everything and making sure the family had everything

they needed, I was able to finish my degree.” — Richard Neal

Scripts Filled

Kelly Markey, senior Director of Development & Alumni Affairs

University of Florida College of Pharmacy

PO Box 103570, Gainesville, FL 32610

352.273.6605 | 352.273.6607 fax